Get the Stockscreener App
14.70
1.31%
-0.1935
Organon Co stock is traded at $14.70, with a volume of 1.05M.
It is down -1.31% in the last 24 hours and down -6.52% over the past month.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
See More
Previous Close:
$14.89
Open:
$14.9
24h Volume:
1.05M
Relative Volume:
0.34
Market Cap:
$3.83B
Revenue:
$6.41B
Net Income/Loss:
$1.30B
P/E Ratio:
2.916
EPS:
5.04
Net Cash Flow:
$646.00M
1W Performance:
-5.56%
1M Performance:
-6.52%
6M Performance:
-22.86%
1Y Performance:
-9.57%
1-Day Range:
$14.66
$14.96
1-Week Range:
$14.66
$15.47
52-Week Range:
$13.87
$23.10
Organon Co Stock (OGN) Company Profile
Name
Organon Co
Sector
Industry
Phone
551-430-6000
Address
30 HUDSON STREET, JERSEY CITY
Compare OGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
14.72 | 3.83B | 6.41B | 1.30B | 646.00M | 5.04 |
|
LLY
Lilly Eli Co
|
885.17 | 827.20B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
86.58 | 386.95B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
JNJ
Johnson Johnson
|
153.98 | 344.63B | 88.82B | 14.07B | 19.03B | 5.79 |
|
ABBV
Abbvie Inc
|
192.21 | 341.01B | 56.33B | 4.28B | 15.62B | 2.40 |
|
MRK
Merck Co Inc
|
88.04 | 251.88B | 64.17B | 17.12B | 14.84B | 6.7297 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-06-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-03-23 | Downgrade | Goldman | Buy → Neutral |
| Sep-21-23 | Initiated | Barclays | Overweight |
| Mar-16-23 | Initiated | Raymond James | Outperform |
| Oct-14-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-06-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-27-22 | Initiated | Goldman | Buy |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-07-21 | Initiated | Piper Sandler | Neutral |
| Sep-01-21 | Initiated | BofA Securities | Buy |
| Jul-22-21 | Initiated | Citigroup | Buy |
| Jun-15-21 | Initiated | JP Morgan | Neutral |
| Jun-11-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-10-21 | Initiated | Evercore ISI | Outperform |
View All
Organon Co Stock (OGN) Latest News
Robeco Institutional Asset Management B.V. Takes $2.26 Million Position in Organon & Co. (NYSE:OGN) - MarketBeat
Private Management Group Inc. Purchases 225,420 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Optimist Retirement Group LLC Has $599,000 Stock Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Sippican Capital Advisors Purchases 21,122 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. (NYSE:OGN) Position Lessened by Exchange Traded Concepts LLC - MarketBeat
Nisa Investment Advisors LLC Trims Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Organon (OGN) Rises Higher Than Market: Key Facts - Yahoo Finance
Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women’s Health - br.ADVFN.com
An excellent week for Organon & Co.'s (NYSE:OGN) institutional owners who own 83% as one-year returns inch higher - Yahoo Finance
OGNOrganon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy - br.ADVFN.com
Organon Recommends Stockholders Reject Below-Market Mini-Tender Offer by TRC Capital Investment Corporation - br.ADVFN.com
Organon (OGN) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Organon & Co. (NYSE:OGN) Shares Purchased by Pacer Advisors Inc. - MarketBeat
DGS Capital Management LLC Acquires New Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Sound Income Strategies LLC Acquires 39,726 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
With 79% ownership, Organon & Co. (NYSE:OGN) boasts of strong institutional backing - Simply Wall St
Organon announces departure of chief commercial officer - MSN
Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025 - Business Wire
Organon Sets Q4 2024 Earnings Date, Confirms No Milestone Expenses Expected - StockTitan
Organon announces departure of chief commercial officer By Investing.com - Investing.com South Africa
Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Organon Announces Cessation of Chief Commercial Officer Role - TipRanks
Organon & Co. (NYSE:OGN) Stock Holdings Lessened by Gilman Hill Asset Management LLC - MarketBeat
Organon & Co. (NYSE:OGN) Upgraded by TD Cowen to Hold Rating - MarketBeat
Why Is Women Health-Focused Organon Stock Trading Higher On Thursday? - MSN
Organon: A Tricky 2025 Awaits, But I'm Happy With A >7% Dividend Yield (OGN) - Seeking Alpha
(OGN) Investment Analysis - Stock Traders Daily
Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune
Organon & Co. set to break its six-day losing streak - MSN
TD Cowen holds Organon stock with $19 target, eyes 2025 outlook - Investing.com Australia
TD Cowen holds Organon stock with $19 target, eyes 2025 outlook By Investing.com - Investing.com South Africa
Organon snaps six days of winning streak - MSN
Wedmont Private Capital Grows Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Is Organon & Co. (OGN) the Best Medical Stock to Buy Under $20? - Insider Monkey
Organon gets expanded FDA approval for VTAMA - MSN
12 Best Medical Stocks To Buy Under $20 - Insider Monkey
Organon (OGN) Stock Moves -0.94%: What You Should Know - Yahoo Finance
Organon Co Stock (OGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Organon Co Stock (OGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Arjona Ferreira Juan Camilo | Head of R&D & CMO |
Aug 11 '24 |
Option Exercise |
0.00 |
11,519 |
0 |
11,532 |
| Morrissey Joseph T. Jr. | Head of Manufacturing |
May 04 '24 |
Option Exercise |
0.00 |
3,604 |
0 |
42,406 |
| Nisita Vittorio | Head of Global Business Svcs |
May 04 '24 |
Option Exercise |
0.00 |
2,078 |
0 |
23,097 |
| Fiedler Susanne | Chief Commercial Officer |
May 04 '24 |
Option Exercise |
0.00 |
4,989 |
0 |
52,253 |
| Ali Kevin | Chief Executive Officer |
May 04 '24 |
Option Exercise |
0.00 |
22,161 |
0 |
147,504 |
| Weaver Kirke | Gen. Counsel & Corp. Secy. |
May 04 '24 |
Option Exercise |
0.00 |
1,248 |
0 |
29,516 |
| Falcione Aaron | Chief Human Resources Officer |
May 04 '24 |
Option Exercise |
0.00 |
2,770 |
0 |
31,364 |
| DiMarco Kathryn | Corporate Controller |
May 04 '24 |
Option Exercise |
0.00 |
1,248 |
0 |
21,398 |
| WALSH MATTHEW M | Chief Financial Officer |
May 04 '24 |
Option Exercise |
0.00 |
8,310 |
0 |
92,419 |
| Stahler Rachel A | Chief Information Officer |
May 04 '24 |
Option Exercise |
0.00 |
3,049 |
0 |
49,282 |
0.97%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):